# Vistagen Therapeutics, Inc.: Form 8-K, filed Oct 9, 2026

- Company: [Vistagen Therapeutics, Inc.](/companies/vtgn.md) (CIK 1411685)
- Form: 8-K
- Filed: 2026-10-09
- Accepted by EDGAR: Oct 9, 2026, 17:15 ET
- Period: 2026-10-07
- Accession: 0001628280-26-065559
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1411685/000162828026065559/vtgn-20261007.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1411685/000162828026065559/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1411685/000162828026065559/vtgn-20261007.htm

Filed Oct 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-065559. Last ingested by Listed: Oct 30, 2026, 17:32 ET. No prices; not investment advice.